Why the AVN Market is Booming – Key Drivers and Future Forecasts

ANIAK, Alaska - May 2, 2025 - PRLog -- Market Overview and Growth Drivers

The global avascular necrosis market is expanding due to several factors, including the rising incidence of bone-related disorders, advancements in diagnostic imaging, and improved treatment options. According to recent studies, the increasing use of corticosteroids in autoimmune diseases and organ transplants contributes significantly to AVN cases. Additionally, lifestyle factors such as alcohol abuse and smoking further elevate the risk, driving demand for effective treatments.

Diagnostic and Treatment Landscape

Early diagnosis of avascular necrosis is crucial to prevent irreversible bone damage. Imaging techniques such as X-rays, MRI scans, and CT scans play a vital role in detecting AVN in its initial stages. MRI is particularly effective in identifying early bone deterioration before structural changes become visible on X-rays.

Current Treatment Approaches

1. Medications – Nonsteroidal anti-inflammatory drugs (NSAIDs) and bisphosphonates are commonly prescribed to manage pain and slow bone degeneration. However, these treatments only provide symptomatic relief and do not reverse bone damage.
2. Core Decompression Surgery – A widely used surgical intervention where doctors remove part of the inner bone to relieve pressure and stimulate new blood vessel growth. This procedure is most effective in early-stage AVN.
3. Bone Grafting – In advanced cases, surgeons may replace damaged bone with healthy bone grafts to restore joint function. Vascularized bone grafts, which include blood vessels, offer better outcomes by promoting blood supply regeneration.

VIEW SOURCE FOR MORE INFORMATION: https://www.globenewswire.com/news-release/2022/08/10/2495734/0/en/Avascular-Necrosis-Market-Size-is-predicted-to-reach-at-USD-1-026-Million-by-2030-registering-a-CAGR-of-6-1-Owing-to-Increasing-Number-of-Medicines-Approvals-from-Regulatory-Agenci.html?f=22&fvtc=5&fvtv=37025363

Emerging Therapies and Innovations

The avascular necrosis market is evolving with new treatment modalities aimed at preserving joint function and delaying surgical interventions. Some promising developments include:

• Stem Cell Therapy – Researchers are exploring stem cell injections to regenerate damaged bone tissue and improve blood flow. Early clinical trials show encouraging results in reducing pain and enhancing bone repair.
• Hyperbaric Oxygen Therapy (HBOT) – This treatment involves breathing pure oxygen in a pressurized chamber to enhance oxygen delivery to affected bones, promoting healing in early AVN cases.
• Biologic Agents – Growth factors and platelet-rich plasma (PRP) therapies are being studied for their potential to accelerate bone regeneration and reduce inflammation.

Click here for more details: https://www.acumenresearchandconsulting.com/avascular-necrosis-market